Image credit: Jasleen Kaur

GW Pharmaceuticals and GNC met with White House on CBD

One company is focused on the future of CBD in supplements. The other, on its future in pharmaceuticals.

CBD
New York

New York’s Cannabis Equity Fund Recalibrates: “The Markets Have Changed” 

Cannabis regulators met on Tuesday for the second time in May to also approve emergency enforcement rules and a settlement related to a lawsuit that blocked licensing in parts of the state.

Regulation

As FDA Looks to Congress for CBD Regs, it Elaborates on Potential Paths Forward 

On Thursday, the FDA pushed its desire to work with Congress on cannabinoid product rules, including delta-8 THC.